Leuvas Therapeutics, Inc.

Leuvas Therapeutics is a biopharmaceutical company developing therapeutics that block leukocyte-vascular interactions (LVI) to develope therapeutics for Refractory epilepsy, Epileptogenesis (following seizure, TBI, stroke) and Alzheimers disease.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.leuvas.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
2416 Tamalpais St,CA 94043-4130
Mountain View
United States
Email
Contact Number
+1 650-968-8625

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Leuvas is leveraging on recent discoveries that dysfunctional endothelium, inflammatory vascular changes and leukocyte-vascular interactions (LVI) underlie disease pathogenesis in epilepsy, Alzheimers Disease and other neurodegenerative diseases.